ArticleProceedings of the National Academy of Sciences of the United States of America2007

Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.

Sylvaine You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.